Depressive behavior and vascular dysfunction: A link between clinical depression and vascular disease?

Journal of Applied Physiology

Volumn 108, Issue 5, 2010, Pages 1041-1051

  D'Audiffret, Alexandre C ^a   Frisbee, Stephanie J ^a   Stapleton, Phoebe A ^a   Goodwill, Adam G ^a   Isingrini, Elsa ^b   Frisbee, Jefferson C ^a  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITÉ DE TOURS   (France)

Author keywords

Clinical depression; Endothelium derived factors; Models of chronic stress; Nitric oxide; Peripheral vascular disease; Vasodilation

Indexed keywords

AUTACOID; BIOLOGICAL MARKER; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HYDROGEN PEROXIDE; NITRIC OXIDE; NOS3 PROTEIN, MOUSE; PROSTAGLANDIN SYNTHASE INHIBITOR; VASOCONSTRICTOR AGENT; VASODILATOR AGENT;

ANIMAL; ANIMAL BEHAVIOR; AORTA; ARTICLE; BAGG ALBINO MOUSE; BLOOD; CHRONIC DISEASE; DEPRESSION; DISEASE MODEL; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; HOSPITALIZATION; HYPERTENSION; INFLAMMATION; INSULIN RESISTANCE; MALE; MENTAL STRESS; METABOLISM; MOUSE; PATHOPHYSIOLOGY; PSYCHOLOGICAL ASPECT; RISK FACTOR; TIME; VASCULAR DISEASE; VASOCONSTRICTION; VASODILATATION;

ANIMALS; AORTA; BEHAVIOR, ANIMAL; BIOLOGICAL MARKERS; CHRONIC DISEASE; CYCLOOXYGENASE INHIBITORS; DEPRESSION; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HYDROGEN PEROXIDE; HYPERTENSION; INFLAMMATION; INFLAMMATION MEDIATORS; INSULIN RESISTANCE; MALE; MICE; MICE, INBRED BALB C; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STRESS, PSYCHOLOGICAL; TIME FACTORS; VASCULAR DISEASES; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS; VASODILATION; VASODILATOR AGENTS;

EID: 77951950364     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.01440.2009     Document Type: Article

References (28)

1. Alexopoulos GS, Meyers BS, Young RC, Campbell S, Silbersweig D, Charlson M. "Vascular depression" hypothesis. Arch Gen Psychiatry 54: 915-922, 1997.
2. Alexopoulos GS, Meyers BS, Young RC, Kakuma T, Silbersweig D, Charlson M. Clinically defined vascular depression. Am J Psychiatry 154: 562-565, 1997. (Pubitemid 27147616)
3. Brown AD, Barton DA, Lambert GW. Cardiovascular abnormalities in patients with major depressive disorder: autonomic mechanisms and implications for treatment. CNS Drugs 23: 583-602, 2009.
4. Barefoot JC, Brummett BH, Helms MJ, Mark DB, Siegler IC, Williams RB. Depressive symptoms and survival of patients with coronary artery disease. Psychosom Med 62: 790-795, 2000. (Pubitemid 32009085)
5. Barefoot JC, Williams RB. Antidepressant use and the risk of myocardial infarction. Am J Med 108: 87-88, 2000. (Pubitemid 30058283)
6. Berkman LF, Blumenthal J, Burg M, Carney RM, Catellier D, Cowan MJ, Czajkowski SM, DeBusk R, Hosking J, Jaffe A, Kaufmann PG, Mitchell P, Norman J, Powell LH, Raczynski JM, Schneiderman N; Enhancing Recovery in Coronary Heart Disease Patients Investigators (ENRICHD). Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. JAMA 289: 3106-3116, 2003.
7. Busija DW, Miller AW, Katakam P, Erdös B. Insulin resistance and associated dysfunction of resistance vessels and arterial hypertension. Minerva Med 96: 223-232, 2005. (Pubitemid 41641239)
8. Chrapko WE, Jurasz P, Radomski MW, Lara N, Archer SL, Le Mellédo JM. Decreased platelet nitric oxide synthase activity and plasma nitric oxide metabolites in major depressive disorder. Biol Psychiatry 56: 129-134, 2004. (Pubitemid 38844788)
9. Davidson KW, Kupfer DJ, Bigger JT, Califf RM, Carney RM, Coyne JC, Czajkowski SM, Frank E, Frasure-Smith N, Freedland KE, Froelicher ES, Glassman AH, Katon WJ, Kaufmann PG, Kessler RC, Kraemer HC, Krishnan KR, Lespérance F, Rieckmann N, Sheps DS, Suis JM; National Heart, Lung, and Blood Institute Working Group. Assessment and treatment of depression in patients with cardiovascular disease: National Heart, Lung, and Blood Institute Working Group Report. Psychosom Med 68: 645-650, 2006.
10. Ducottet CC. Belzung, Correlations between behaviours in the elevated plus-maze and sensitivity to unpredictable subchronic mild stress: evidence from inbred strains of mice. Behav Brain Res 156: 153-162, 2005.
11. Friedman G, Ben-Yehuda A, Dabach Y, Hollander G, Babaey S, Ben-Naim M, Stein O, Stein Y. Macrophage cholesterol metabolism, apolipoprotein E, and scavenger receptor AI/II mRNA in atherosclerosissusceptible and -resistant mice. Arterioscler Thromb Vasc Biol 20: 2459-2464, 2000.
12. Gass P, Reichardt HM, Strekalova T, Henn F, Tronche F. Mice with targeted mutations of glucocorticoid and mineralocorticoid receptors: models for depression and anxiety? Physiol Behav 73: 811-825, 2001. (Pubitemid 32885569)
13. Glassman AH, O'Connor CM, Califf RM, Swedberg K, Schwartz P, Bigger JT Jr, Krishnan KR, van Zyl LT, Swenson JR, Finkel MS, Landau C, Shapiro PA, Pepine CJ, Mardekian J, Harrison WM, Barton D, Mclvor M. Sertraline Antidepressant Heart Attack Randomized Trial (SADHEART) Group. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 288: 701-709, 2002. [Corrigendum: JAMA 288: 1720, 2002].
14. Kim F, Pham M, Maloney E, Rizzo NO, Morton GJ, Wisse BE, Kirk EA, Chait A, Schwartz MW. Vascular inflammation, insulin resistance, and reduced nitric oxide production precede the onset of peripheral insulin resistance. Arterioscler Thromb Vasc Biol 28: 1982-1988, 2008.
15. Mineur YS, Belzung C, Crusio WE. Effects of unpredictable chronic mild stress on anxiety and depression-like behavior in mice. Behav Brain Res 175: 43-50, 2006. (Pubitemid 44691920)
16. Mineur YS, Prasol DJ, Belzung C, Crusio WE. Agonistic behavior and unpredictable chronic mild stress in mice. Behav Genet 33: 513-519, 2003. (Pubitemid 37243297)
17. Miyoshi T, Matsumoto AH, Shi W. Paradoxical increase in LDL oxidation by endothelial cells from an atherosclerosis-resistant mouse strain. Atherosclerosis 192: 259-265, 2007. (Pubitemid 46726326)
18. Neves VJ, Moura MJ, Tamascia ML, Ferreira R, Silva NS, Costa R, Montemor PL, Narvaes EA, Bernardes CF, Novaes PD, Marcondes FK. Proatherosclerotic effects of chronic stress in male rats: altered phenylephrine sensitivity and nitric oxide synthase activity of aorta and circulating lipids. Stress 12: 320-327, 2009.
19. Porsolt RD. Animal models of depression: utility for transgenic research. Rev Neurosci 11: 53-58, 2000. (Pubitemid 30006576)
20. Penninx BW, Beekman AT, Honig A, Deeg DJ, Schoevers RA, van Eijk JT, van Tilburg W. Depression, and cardiac mortality: results from a community-based longitudinal study. Arch Gen Psychiatry 58: 221-227, 2001. (Pubitemid 32209674)
21. Rudisch B, Nemeroff CB. Epidemiology of comorbid coronary artery disease and depression. Biol Psychiatry 54: 227-240, 2003. (Pubitemid 37267853)
22. Santarelli L, Saxe M, Gross C, Surget A, Battaglia F, Dulawa S, Weisstaub N, Lee J, Duman R, Arancio O, Belzung C, Hen R. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301: 805-809, 2003. (Pubitemid 36962615)
23. Venables MC, Jeukendrup AE. Physical inactivity and obesity: links with insulin resistance and type 2 diabetes mellitus. Diabet Metab Res Rev 25, Suppl 1: S18-S23, 2009.
24. Wiernsperger N, Nivoit P, De Aguiar LG, Bouskela E. Microcirculation and the metabolic syndrome. Microcirculation 14: 403-438, 2007.
25. Willner P. Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation. Psychopharmacology (Berl) 134: 319-329, 1997. (Pubitemid 28023396)
26. Willner P. Animal models of depression: validity and applications. Adv Biochem Psychopharmacol 49: 19-41, 1995.
27. Yalcin I, Belzung C, Surget A. Mouse strain differences in the unpredictable chronic mild stress: a four-antidepressant survey. Behav Brain Res 193: 140-143, 2008.
28. Yalcin I, Aksu F, Belzung C. Effects of desipramine and tramadol in a chronic mild stress model in mice are altered by yohimbine but not by pindolol. Eur J Pharmacol 514: 165-174, 2005. (Pubitemid 40720357)